InspireMD Inc (NSPR)

[Value_Investor]

NSPR has good news today --- see the link below!

Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks (GMED, INSP, and NSPR).

Inspire Medical Systems

On Friday, Maple Grove, Minnesota headquartered Inspire Medical Systems Inc.'s stock ended the session 2.80% higher at $30.84. A total volume of 274,799 shares was traded. Shares of the Company, which focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea, are trading 5.56% above its 50-day moving average.

On May 29th, 2018, research firm Wells Fargo initiated an 'Outperform' rating on the Company's stock.

On May 30th, 2018, Inspire Medical Systems announced that its management team will be presenting at the Goldman Sachs 39th Annual Global Healthcare Conference on June 12th, 2018 at the Terranea Resort in Rancho Palos Verdes, California. The Company is scheduled to present at 10:00 a.m. PT. The free technical report on INSP can be accessed at:

www.wallstequities.com/registration/?symbol=INSP

InspireMD

Tel Aviv, Israel headquartered InspireMD Inc.'s stock ended the day flat at $1.19 with a total trading volume of 401,069 shares. The stock is trading 8.83% below its 50-day moving average. Shares of the Company, which focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases, have an RSI of 49.89.

On May 16th, 2018, InspireMD announced that it has received regulatory approval for the CGuard™ Embolic Prevention System and MGuard Prime™ from the Ministry of Health in Ecuador. Both of these devices utilize the Company's patented MicroNet™ technology. Sign up for free on Wall St. Equities and claim the latest report on NSPR at:

www.wallstequities.com/registration/?symbol=NSPR

https://finance.yahoo.com/news/free-daily-technical-summary-reports-113000889.html